Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 154 publications
Novel Immunotherapy Agents in Early-Phase Trials for Head and Neck Cancer.
Journal: JAMA network open
Published: July 16, 2026
Development and external validation of a prognostic score associated with poor outcomes in patients receiving immune checkpoint blockade-containing therapies enrolled in early-phase clinical trials.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 10, 2026
Clinical determinants of survival outcomes and acute toxicity after adoptive cellular therapy for solid tumors.
Journal: Frontiers in immunology
Published: April 06, 2026
Genomic co-alterations and immune-related adverse events shape outcomes of thymic malignancies treated with immune checkpoint inhibitors.
Journal: NPJ precision oncology
Published: March 10, 2026
Cytokine Release Symptoms rather than Syndromes: A call for Granular Reporting of Cytokine Related Adverse Events in Clinical Trials.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 26, 2026
Cytokine release symptoms rather than syndromes: a call for granular reporting of cytokine-related adverse events in clinical trials.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 26, 2026
Targeting Regulatory T Cells for Cancer Immunotherapy: Promises and Pitfalls.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 26, 2026
Targeting regulatory T cells for cancer immunotherapy: promises and pitfalls.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 26, 2026
Future approaches to immune base biomarkers.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 04, 2025
Future approaches to immune-based biomarkers.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 04, 2025
A multi-institutional perspective on tarlatamab administration and management of CRS/ICANS.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 17, 2025
Telemedicine as a gateway to early-phase oncology trials: lessons from 14 000 patients and future directions for global access and equity.
Journal: The oncologist
Published: September 30, 2025
Last Updated: 09/26/2026